✦ LIBER ✦

7132 Safety and efficacy of sorafenib in patients with advanced renal cell carcinoma (RCC) with varying histologies: results from the phase 3, open access study of sorafenib in European patients with advanced RCC (EU-ARCCS)

✍ Scribed by Bokemeyer, C.; Gore, M.; Bracarda, I.; Richel, N.; Staehler, D.; von der Maase, H.; Stierner, U.; Strauss, U.P.; Burock, K.; Porta, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

7137 Final analysis of a large open-labe

✍ Beck, J.; Procopio, I.; Negrier, S.; Keilholz, D.; Sczylik, C.; Bokemeyer, C.; S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

7130 Efficacy and safety of sorafenib in

✍ Bukowski, R.; Eisen, T.E.; Stadler, W.S.; Szczylik, C.S.; Oudard, O.S.; Siebels, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

254 A SUBANALYSIS OF PATIENTS WITH AND W

✍ M. Staehler; G. Procopio; U. Keilholz; S. Negrier; C. Szczylik; J. Beck; U.P. St 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 506 KB

A LARGE OPEN-LABEL, NON-COMPARATIVE, PHA

✍ J. Beck; E. Verzoni; S. Negrier; U. Keilholz; C. Szczylik; S. Bracarda; C. Bokem 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

6519 Efficacy and safety of sorafenib in

✍ Llovet, J.; Cheng, A.; Qin, S.; Shan, M.; Nadel, A.; Burock, K.; Forner, A.; Zou 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

4506 ORAL A large open-label, non-compar

✍ Beck, J.; Bajetta, E.; Escudier, B.; Negrier, S.; Keilholz, U.; Szczylik, C.; Me 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB